Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • DiR (DiIC 18 (7)): Benchmarking Deep-Red Membrane Labeling f

    2026-06-06

    DiR (DiIC 18 (7)): Deep-Red Membrane Probe for Reliable EV and Cell Tracking

    Executive Summary: DiR (DiIC 18 (7)) is a deep-red, lipophilic fluorescent dye designed for efficient membrane labeling in both live and fixed biological samples, with robust applications in extracellular vesicle (EV) tracking and neuronal tracing (APExBIO product information). This probe integrates rapidly into lipid bilayers, producing red fluorescence with minimal cytotoxicity, and offers long-term signal retention in vitro (up to four weeks) and in vivo (up to one year). Its near-infrared excitation/emission spectrum ensures deep tissue imaging and low autofluorescence, supporting sensitive detection in complex models (Liu et al., 2024). DiR’s performance benchmarks and workflow parameters provide a foundation for Engage & Evasion strategies in regenerative and ischemic disease research.

    Biological Rationale

    Cellular and extracellular vesicle (EV) tracking requires probes that bind stably to lipid membranes, offer minimal cytotoxicity, and deliver robust fluorescence signals over extended periods. DiR (DiIC 18 (7)) is optimized for these demands, integrating into the outer leaflet of cell membranes by virtue of its aliphatic chains, ensuring comprehensive plasma membrane staining (DiR for Long-Term Membrane Labeling & EV Tracking). The deep-red/near-infrared emission reduces signal interference from tissue autofluorescence, which is critical for in vivo imaging scenarios. These features are particularly relevant in the context of regenerative medicine and ischemic disease, where precise cell and EV migration tracking underpins the development of novel therapies (Liu et al., 2024).

    Mechanism of Action of DiR (DiIC 18 (7))

    DiR (DiIC 18 (7)) is a lipophilic carbocyanine dye with two long-chain alkyl tails and a conjugated aromatic core, driving its spontaneous incorporation into lipid bilayers. Upon integration, it diffuses laterally across the membrane, providing uniform staining of the plasma membrane and vesicular surfaces (APExBIO). The dye fluoresces in the near-infrared region (excitation: ~748 nm, emission: ~780 nm), facilitating deep tissue penetration and real-time imaging with low background noise (DiR Empowers Advanced EV Tracking). DiR remains membrane-bound without translocating to the cytosol or nucleus, ensuring signal specificity for cell membrane staining and EV tracking (Illuminating Engage & Evasion in EV Therapy).

    Evidence & Benchmarks

    • DiR labels cell membranes and EVs with high specificity and signal intensity, maintaining fluorescence for up to four weeks in vitro (APExBIO product info).
    • In vivo, DiR-labeled EVs are detectable for up to one year post-administration, supporting long-term tracking studies (Liu et al., 2024).
    • DiR exhibits minimal cytotoxicity across a range of cell lines at concentrations up to 5 μM, preserving cell viability and function (Protocol review).
    • Near-infrared excitation/emission (748/780 nm) enables deep tissue imaging with low autofluorescence and high signal-to-noise, outperforming traditional green/red dyes in animal models (Liu et al., 2024).
    • DiR is insoluble in water but dissolves at ≥19.8 mg/mL in DMSO and ≥29.35 mg/mL in ethanol; optimal storage is at -20°C, protected from light and moisture, with solid form stable for one year (product documentation).

    This article complements 'DiR (DiIC 18 (7)) Empowers Advanced EV Tracking & Imaging' by providing quantitative stability and workflow guidance, extending the mechanistic insights of the referenced overview. It also offers practical integration parameters beyond the focus of 'Engage & Evasion Strategy: Enhancing EV Therapy via MPS Escape', which primarily addresses systemic delivery strategies, not labeling durability.

    Applications, Limits & Misconceptions

    DiR (DiIC 18 (7)) is applied across in vitro and in vivo models for:

    • Live cell membrane imaging: Enables visualization of membrane dynamics in real time.
    • Fixed tissue membrane labeling: Facilitates post-fixation analysis and histological mapping of labeled cells and EVs.
    • Neuronal tracing dye: Supports both anterograde and retrograde labeling in neuronal circuit studies (APExBIO).
    • Long-term EV tracking: Maintains detectable fluorescence over extended periods, supporting studies of EV biodistribution (Liu et al., 2024).
    • Cell-cell fusion/adhesion monitoring: Tracks dynamic interactions in co-culture and tissue systems.

    Common Pitfalls or Misconceptions

    • DiR is not soluble in water; direct dilution without organic solvent leads to precipitation and poor labeling (product info).
    • Over-labeling can cause dye aggregation on membranes, affecting fluorescence uniformity and potentially cell viability above recommended concentrations.
    • DiR does not label cytoplasmic or nuclear compartments; signal is confined to the lipid bilayer.
    • Photobleaching is minimal but can occur with prolonged, intense illumination—minimize light exposure during imaging setup.
    • DiR cannot be used for real-time tracking of rapidly dividing cells beyond ~4 weeks in vitro, as dilution through cell division will reduce signal intensity.

    Workflow Integration & Parameters

    Protocol Parameters

    • Stock solution preparation: Dissolve DiR in DMSO (≥19.8 mg/mL) or ethanol (≥29.35 mg/mL); avoid water to prevent precipitation (APExBIO).
    • Working concentration: Typical in vitro labeling concentration is 1–5 μM; adjust according to cell type and application.
    • Incubation: Incubate cells or EVs with DiR solution for 10–30 minutes at 37°C, protected from light.
    • Washing: Remove unbound dye by washing 2–3 times with PBS or compatible buffer.
    • Storage: Store labeled samples at 4°C (short term) or -20°C for longer durations; avoid repeated freeze-thaw cycles.
    • Imaging: Excite at 748 nm, collect emission at ~780 nm; use appropriate filter sets for near-infrared fluorescence.
    • In vivo: For animal studies, DiR-labeled EVs can be tracked for up to one year post-injection (Liu et al., 2024).

    For additional troubleshooting and optimization, see 'DiR (DiIC 18 (7)) for Long-Term Membrane Labeling & EV Tracking', which details protocol adaptations for different cell types and labeling durations in the context of Engage & Evasion workflows.

    Conclusion & Outlook

    DiR (DiIC 18 (7))—commercialized by APExBIO—provides a well-validated solution for durable, sensitive, and low-background membrane labeling in both in vitro and in vivo research. Its long-term fluorescence, minimal cytotoxicity, and compatibility with the latest Engage & Evasion strategies make it a core reagent for tracking cellular and vesicular therapeutics in regenerative and ischemic disease models (Liu et al., 2024). Ongoing refinements in workflow integration and imaging hardware will likely further enhance sensitivity and throughput in EV biodistribution studies. For context on strategic advances in EV therapy, see 'Engage & Evasion: Enhancing EV Therapy by MPS Escape Mechanisms', which discusses systemic delivery bottlenecks—this article situates DiR as the enabling platform for such translational imaging protocols.